Pharmacokinetics and the Nursing Process Flashcards
Pharmacokinetics
- determining how much of administered dose gets to its site of action
- four major pharmacokinetic processes include drug absorption, distribution, metabolism, and excretion
Pharmacodynamics
- the impact a drug has on the body
- looks at drug receptor interaction, the patient’s functional state, and placebo effects
Pharmaceutical properties of drugs
the medicinal properties of a drug; how it can benefit the individual it is effecting by minimizing the harm done
Pharmacokinetics: Absorption
- the movement of a drug from its site of administration into the blood
- amt of absorption helps to determine how intense effects will be
Pharmacokinetics: Distribution
- defined as the transport of a drug in the body fluids from the bloodstream to the various tissues of the body & ultimately the site of action
Pharmacokinetics: Metabolism
- also known as biotransformation
- defined as the enzymatic alteration of drug structute
- the process of chemically inactivating a drug by converting it into a more water-soluble compound or metabolite that can be excreted from the body
- occurs in the liver
Pharmacokinetics: Excretion
- the process by which drugs & metabolites are eliminated from the body, primarily through the kidneys
Blood Brain Barrier
- only drugs that are lipid soluble or have a transport system have the ability to cross over the blood brain barrier to a significant degree and effect the CNS
Placental Drug Transfer
- membranes of the placenta do not constitute an absolute barrier to the passage of drugs
- movement across occurs from circulation, active transport, and even by passing directly through if they are lipid soluble
The Stages of Drug Research
- preclinical testing
- clinical testing which includes 4 phases
Phase I clinical testing of drugs
- initial pharmacologic evaluation
- small group of normal humans is tested to observe pharmacokinetics
Phase II clinical testing of drugs
- limited controlled evaluation
- selected group of humans with targeted disease is tested. Subjects are monitored for effectiveness & side effects
Phase III clinical testing of drugs
- extended clinical evaluation
- humans with targeted disease are tested to determine clinical effectiveness, drug safety, estimated dosage range or tolerated dosage
Phase IV clinical testing of drugs
- drug has been approved by the FDA and is now cleared to be prescribed so that it can be observed in a larger manor
Properties of a nursing assessment
- this is the collection of baseline data in order to evaluate the therapeutic and adverse effects on a person, as well as the identification of high risk patients and the patient’s capacity for self care
- the nurse must ask about drug history, surgery history, family history, etc. in order to assess how to treat the patient properly